Company / Cost of Revenue
Embecta Corp. Cost of Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$403.6M
FY2025
5-year range
$322.9M / $403.6M
FY2021-FY2025
Trend
+4.0%
vs FY2024
Sector context
#71 of 113
Health Care
What the data says
At $404M, Embecta Corp.'s cost of revenue ranks #43 of 113 in the Health Care sector. Cost of Revenue has increased for 3 consecutive years, from $323M in FY2022 to $404M in FY2025.
Based on SEC 10-K filings.
$404M in FY2025 with a 5-year CAGR of +4.6%.
Increased from $371M to $404M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- +4.6%
- 10-Year CAGR
- -
Sector benchmark
#43 of 113 in Health CareTop 37% of 113This company $403.6M Sector average $11.3B
▼
-96.4% below sector average
Key checks
Key Insights
- Embecta Corp.'s cost of revenue has grown for 3 consecutive years.
- 5-year CAGR of +4.6%, indicating consistent growth.
- In FY2025, cost of revenue increased 4.0% year-over-year.
- Ranks #71 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $403.6M | +4.0% |
| FY2024 | $387.9M | +4.6% |
| FY2023 | $370.9M | +14.9% |
| FY2022 | $322.9M | -11.5% |
| FY2021 | $364.9M | +13.0% |
| FY2020 | $322.9M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026